Sign in

Yong Li

@precisionmedicine.bsky.social
549 followers 395 following 97 posts

Associate Director of Bioinformatics and Software at Illumina. Unleashing the power of the genome through SW and AI. #PrecisionMedicine #Cancer #MECFS #RareDisease

PostsRepliesMedia
Reposted by Yong Li
Eric Topol @erictopol.bsky.social · 19/02/2026
Predicting when symptoms of Alzheimer's disease will occur with a single elevated p-tau217 blood test and a person's age, even 20+ years in advance @naturemedicine.bsky.social nature.com/articles/s41...
427477
Yong Li @precisionmedicine.bsky.social · 10/01/2026
Big news: Eric Green, former director of NHGRI, has been appointed CMO of Illumina, effective Feb 2, 2026. Eric is a key architect of the Human Genome Project and a driving force behind genomic medicine. Good move from Illumina, and great to see the focus on bringing genome to medicine!
illumina.com
Illumina Appoints Dr. Eric Green as Chief Medical Officer
000
Yong Li @precisionmedicine.bsky.social · 14/09/2025
Is it the bigger the better with PGx testing? Response from Quest Diagnostics: On September 4, 2025, they launched a revamped pharmacogenomics (PGx) testing service, offering a narrower panel and streamlined results reporting. What do you think?
newsroom.questdiagnostics.com
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
New Service Empowers Clinicians with Personalized Insights from Coriell Life Sciences to Optimize Prescribing Across Specialties SECAUCUS, N.J., Sept. 4, 2025 /PRNewswire/ -- Quest Diagnostics...
000
Yong Li @precisionmedicine.bsky.social · 14/09/2025
A PNAS study reveals the mechanism of CACNA1C-schizophrenia GWAS associations: A variable region of the intron 3 VNTR repeats in CACNA1C, in strong linkage with risk SNPs, lowers CACNA1C expression in the brain, potentially disrupting CaV1.2 channel function vital for neuronal signaling and memory.
pnas.org
Structure of a polymorphic repeat at the CACNA1C schizophrenia locus | PNAS
Genetic variation within intron 3 of the CACNA1C calcium channel gene is associated with schizophrenia and other neuropsychiatric disorders, but an...
021
Yong Li @precisionmedicine.bsky.social · 30/07/2025
An interesting AI-driven method for gene-set analysis was just published in Nature Methods. The bioinformatics tool ‘GeneAgent’ pairs GPT-4 with biological database checks to reduce LLM hallucinations in GSEA, outperforming GPT-4 alone with 92% accuracy (per expert review). #genomics #LLM
nature.com
GeneAgent: self-verification language agent for gene-set analysis using domain databases - Nature Methods
GeneAgent is a language agent using large language models and self-verification to improve gene-set function annotation.
010
Yong Li @precisionmedicine.bsky.social · 29/06/2025
For researchers studying human diseases and health via #epigenetics, the Epigenetics Research Grant from Illumina might be of interest. Deadline: Aug 24, 2025. Eligible: genomic scientists at academic, nonprofit, or for-profit institutions. #ResearchGrant
illumina.com
Illumina Epigenetics Research Grant | Innovations using epigenetics research
Research grant contest to improve how epigenetics can impact disease using DNA methylation studies.
062
Yong Li @precisionmedicine.bsky.social · 26/05/2025
New @commsbio.nature.com study: A father’s weight during puberty may shape their child’s health. Overweight adolescent dads passed on epigenetic changes linked to asthma risk, lower lung function & higher BMI in kids. Puberty could be a critical window for transgenerational health. #epigenetics
nature.com
Father’s adolescent body silhouette is associated with offspring asthma, lung function and BMI through DNA methylation - Communications Biology
Epigenome association study of father’s preconception body silhouette with offspring DNA methylation, providing mechanistic insight into how epigenetic inheritance impacts offspring obesity, asthma an...
011
Yong Li @precisionmedicine.bsky.social · 05/05/2025
At AACR 2025, the ROME trial showed combining tissue + liquid biopsies improves survival in advanced tumors. Median OS hit 11 months when two biopsies matched. Discordance was highest in PI3K/PTEN/AKT/mTOR & ERBB2 pathways—highlighting the importance of dual profiling to capture tumor heterogeneity.
pharmacytimes.com
AACR 2025: Tailored Treatment Guided by Combined Tissue and Liquid Biopsies May Improve Outcomes in Advanced Solid Tumors
The phase 2 ROME trial demonstrated that combining tissue and liquid biopsies to guide tailored therapy in advanced solid tumors significantly improves survival outcomes compared to standard of care o...
010
Yong Li @precisionmedicine.bsky.social · 04/05/2025
Illumina and Ovation.io are developing the first real-world dataset to integrate clinical and #multiomics data from 25,000 patients on GLP-1 therapies. This pioneering effort aims to uncover how biology & genetics shape individual treatment responses, enable personalized care for #diabetes patients.
ovation.io
Home - Genomic Data - Ovation.io
Ovation is a genomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine. By generating high-quality genomic data linked to rich, longitudinal phen...
010
Yong Li @precisionmedicine.bsky.social · 04/05/2025
Kabuki syndrome type 1 (KS1) is a rare genetic disorder. A causal Alu insertion was identified in a unsolved Kabuki syndrome patient - amazingly - through DNA methylation signature. It's the first documentation of Alu insertion as a molecular mechanism responsible for KS1. #RareDisease
clinicalepigeneticsjournal.biomedcentral.com
Reverse genotyping: unveiling Alu element insertion as a new cause of Kabuki syndrome using DNA methylation signature - Clinical Epigenetics
Kabuki syndrome type 1 (KS1) is a monogenic disorder arising from pathogenic variants within KMT2D and characterized by syndromic neurodevelopmental delay. We report the retrospective identification o...
020
Yong Li @precisionmedicine.bsky.social · 30/04/2025
The FDA recently missed the approval deadline for a biotech company's #raredisease drug, may be linked to significant job cuts at the FDA, which have raised concerns about the agency's ability to handle drug reviews efficiently.
biopharmadive.com
FDA misses approval deadline for biotech’s rare disease drug
The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.
000
Yong Li @precisionmedicine.bsky.social · 21/04/2025
A new Cell article highlights how #geroscience is moving toward clinical use via precision #geromedicine. With tools like epigenetic clocks, scientists are developing personalized anti-aging therapies—senolytics, tailored diets, and more—to target aging and boost healthspan. Exciting direction!
cell.com
From geroscience to precision geromedicine: Understanding and managing aging
The science of aging, geroscience, translates to its medical application, or geromedicine. This transition will be facilitated by systematic omics technologies quantifying pro-aging (gerogenic) and an...
000
Yong Li @precisionmedicine.bsky.social · 20/04/2025
Could vaccines help prevent Alzheimer’s disease? Recent studies suggest that some viruses like HSV-1 & VZV may accelerate Alzheimer’s disease via brain inflammation, while #vaccines, especially for shingles, may reduce it. Evidence is growing, but more research is needed.
nature.com
Do infections have a role in Alzheimer’s disease?
The suggestion that pathogens play a part in driving dementia is not as niche as it once was, but the evidence remains inconclusive.
030
Yong Li @precisionmedicine.bsky.social · 12/04/2025
A new study in @naturecomms.bsky.social reports a novel PLpro inhibitor that improves outcomes in a preclinical model of #longCOVID. This compound shows promise in reducing lung pathology and brain dysfunction, offering potential for future treatments.
nature.com
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID - Nature Communications
A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle that P...
1115
Yong Li @precisionmedicine.bsky.social · 09/04/2025
@labcorp.bsky.social has launched a U.S. blood test to aid Alzheimer’s diagnosis. It measures ptau-217/beta amyloid 42, potentially cutting reliance on imaging/CSF tests. With 95% sensitivity & specificity, it could significantly shorten the current 2–3 year time from first symptoms to diagnosis.
labcorp.com
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Lab...
021
Yong Li @precisionmedicine.bsky.social · 05/04/2025
A new study shows that Pharmacogenetics test results can change with updated interpretation methods. Many past #PGx interpretations, e.g. on CYP2D6 and CYP2C19, may be outdated—potentially changing metabolizer status & drug response assessments. Time to reanalyze the old genetic data?
tandfonline.com
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing
Providers can use combinatorial pharmacogenomic panels to aid psychiatric medication prescribing. Results are typically documented in static documents which list the genotype and predicted phenotyp...
010
Yong Li @precisionmedicine.bsky.social · 05/04/2025
Autoimmune diseases have higher comorbidity with cancer. A new @science.org study however found that the 4H2 autoantibody, derived from lupus, may help target cancer cells. This surprising link could open the door to a new class of promising treatment strategies bridging autoimmunity and oncology.
science.org
A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells
Delivery of autoimmune disease–associated antibodies activates the immune system to fight glioblastomas.
053
Yong Li @precisionmedicine.bsky.social · 05/04/2025
A study from Yale researchers links persistent spike protein to post-COVID-19 vaccination syndrome, using data from 42 patients and 22 controls. Other findings include immune dysregulation, Epstein-Barr virus reactivation (also linked to #MECFS and #LongCovid), and neuromodulatory deficiencies.
medrxiv.org
Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination
COVID-19 vaccines have prevented millions of COVID-19 deaths. Yet, a small fraction of the population reports a chronic debilitating condition after COVID-19 vaccination, often referred to as post- va...
051
Yong Li @precisionmedicine.bsky.social · 02/04/2025
New AI tools like InstaNova are transforming protein sequencing by rapidly identifying proteins, even unknown ones, from mass spec data. AI’s efficiency surpasses traditional methods, unlocking insights into millions of protein variations.
science.org
The AI revolution comes to protein sequencing
New systems can identify unknown proteins in samples from diseased tissue, the environment, and archaeological sites
062
Yong Li @precisionmedicine.bsky.social · 31/03/2025
Columbia’s Center for Solutions for ME/CFS, a key research hub, has to halted its work due to Trump-era funding cuts, stalling clinical progress. #MECFS remains severely underfunded—NIH allocated just 3-7% of typical disease funding (2015-2019). Urgent investment is needed.
fiercebiotech.com
'It's just ugly': Federal funding cuts to Columbia University leave chronic fatigue syndrome research in limbo
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submitted a paper for publication that suggests certain approved drugs could possibly be repurposed for a severe fatigue co | ...
031
Yong Li @precisionmedicine.bsky.social · 31/03/2025
#LongCovid affects doctors too. GP Dr. Ben Sinclair, a former triathlete, battled severe fatigue and brain fog. Now, he’s using his experience to help others, launching one of the UK’s first online long Covid clinics focused on gut health, mental well-being, and patient-centered care.
telegraph.co.uk
‘I was bed bound with long Covid but as a GP I found strategies for me and my patients to cope’
Dr Ben Sinclair battled long Covid before opening specialist clinics to help other sufferers
042
Reposted by Yong Li
New York Genome Center @nygenome.org · 27/03/2025
We are proud to announce Bing Ren, PhD, as the new Scientific Director & CEO of the New York Genome Center Dr. Ren brings his expertise in the fields of genomics & epigenetics to the NYGC & Columbia University, where he will hold a joint appointment. For more on Dr. Ren: bit.ly/3DJXtah
bit.ly
Bing Ren Appointed Scientific Director and Chief Executive Officer of the New York Genome Center - March 27, 2025
Read about Bing Ren Appointed Scientific Director and Chief Executive Officer of the New York Genome Center at the New York Genome Center on March 27, 2025
15912
Yong Li @precisionmedicine.bsky.social · 31/03/2025
A @naturerevgenet.bsky.social article by Fu et al. reviews how long-read sequencing advances DNA #methylation analysis, aiding insights into gene regulation & disease. It discusses computational tools for methylation detection and genomic integration, highlighting challenges and future directions.
nature.com
Computational analysis of DNA methylation from long-read sequencing - Nature Reviews Genetics
Long-read sequencing technologies can directly profile methylation modifications across the genome. In this Review, Fu et al. overview the long-read computational tools to identify and compare methyla...
020
Yong Li @precisionmedicine.bsky.social · 22/03/2025
A study using All of Us data revealed that among 60,135 cancer patients, 73% had a family history, yet only 281 (0.5%) had documented genetic testing. There’s significant room to enhance #PrecisionOncology by improving EHR data standardization, documentation, and access to genetic testing.
110
Yong Li @precisionmedicine.bsky.social · 15/03/2025
Homo sapiens arrived in Europe 50,000–60,000 years ago with dark skin, hair, and eyes, says Ghirotto. Lighter traits appeared 14,000 years ago but stayed rare until 3,000 years ago. In some areas, dark skin lasted into the Copper Age. A striking selective sweep on skin color—surprised?
011
Yong Li @precisionmedicine.bsky.social · 15/03/2025
A @newscientist.com article: AI scientists are sceptical that modern models will lead to AGI. In a survey of AI researchers, most say current AI models are unlikely to lead to artificial general intelligence with human-level capabilities, even as companies invest billions of dollars in this goal
newscientist.com
AI scientists are sceptical that modern models will lead to AGI
In a survey of AI researchers, most say current AI models are unlikely to lead to artificial general intelligence with human-level capabilities, even as companies invest billions of dollars in this go...
000
Yong Li @precisionmedicine.bsky.social · 08/03/2025
Easy-to-use software & reproducible code are key for precision medicine adoption. A new Tumor Molecular Pathology Toolkit published in Cancer Cell aims at assigning TCGA tumor subtypes to new samples, improving cancer subtyping in clinics & aiding treatment selection. #PrecisionOncology
cell.com
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets
Ellrott et al. provide a means to assign patient samples from clinical trials and other cancer genome studies to published TCGA molecular subtypes. Applying machine learning to data from five differen...
000
Yong Li @precisionmedicine.bsky.social · 03/03/2025
A study reveals that Nanopore and PacBio sequencing fail to capture Y-linked Drosophila exons near satellite sequences, despite deep coverage. In contrast, Illumina #sequencing successfully assembles these regions, highlighting a bias in long-read technologies. #Genomics
biorxiv.org
Strong sequencing bias in Nanopore and PacBio prevents assembly of Drosophila melanogaster Y-linked genes
Nanopore and PacBio are generally considered free from sequence composition bias, a key factor—alongside read length—that explains their success in producing high quality genome assemblies. However, o...
100
Reposted by Yong Li
Eric Topol @erictopol.bsky.social · 19/02/2025
Our thymus, a critical source and trainer of T cells, involutes with aging. 2 new studies find a growth factor (FGF21) that delays involution (in mouse models) and may be a way to rejuvenate our immune system and promote healthy aging in the future.
1219237
Yong Li @precisionmedicine.bsky.social · 17/02/2025
Researchers at the National University of Singapore published a personalized cancer treatment strategy using red blood cell-derived vesicles (RBCEVs) to deliver antisense oligonucleotides (ASOs). This targeted approach suppresses EGFR in mutated cancer cells, sparing normal cells. #PrecisionOncology
thelancet.com
Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer
Overall, by harnessing the specificity and efficacy of ASOs, we present an effective and adaptable therapeutic platform for NSCLC treatment.
000
Yong Li @precisionmedicine.bsky.social · 17/02/2025
UC San Francisco researchers are developing a next-gen radiation therapy that precisely targets tumors while sparing healthy tissue. Building on Dr. Kevan Shokat’s KRAS research, it eliminated lung cancer in mice with minimal side effects. Will it improve outcomes for KRAS-driven cancers in humans?
scitechdaily.com
Scientists Just Made Cancer Radiation Therapy Smarter, Safer, and More Precise
Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation while sparing healthy tissues. By using a KRAS-targeting drug to mark cancer...
010
Yong Li @precisionmedicine.bsky.social · 16/02/2025
In a recent letter to the European Journal of Applied Physiology, Garbsch et al. critique a study by Berg et al. that found no differences in max oxygen uptake between #LongCOVID patients and controls, citing a small sample size and selective patient exclusion. link.springer.com/article/10.1...
link.springer.com
No impairment of maximal oxygen uptake in patients diagnosed with long COVID? - European Journal of Applied Physiology
European Journal of Applied Physiology -
020
Yong Li @precisionmedicine.bsky.social · 11/02/2025
For those interested in measuring biological age, a new study shows that sample type impacts accuracy. Analyzing 284 tissue samples from 83 people (ages 9–70), researchers found major differences in epigenetic clock estimates, with some oral vs. blood-based measures varying by nearly 30 years.
onlinelibrary.wiley.com
Cross‐tissue comparison of epigenetic aging clocks in humans
We tested the within-person comparability of common epigenetic clocks across five tissue types: buccal epithelial, saliva, dry blood spots, buffy coat (i.e., leukocytes), and peripheral blood mononuc...
010
Yong Li @precisionmedicine.bsky.social · 11/02/2025
Australian research finds brain swelling in #LongCOVID and #MECFS patients, linked to memory and concentration issues. MRI showed a significantly larger hippocampal volume in affected individuals compared to healthy controls. The study included 17 long COVID, 29 ME/CFS patients, and 15 controls.
journals.plos.org
Hippocampal subfield volume alterations and associations with severity measures in long COVID and ME/CFS: A 7T MRI study
Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients share similar symptoms including post-exertional malaise, neurocognitive impairment, and memory loss. The neurocogni...
1107
Yong Li @precisionmedicine.bsky.social · 11/02/2025
DeepGEM, an AI model, accurately detects KRAS and EGFR alterations using NSCLC histological images alone (accuracy: 0.79–0.96 for KRAS, 0.80–0.95 for EGFR). It can even generates spatial mutation maps, offering a cost-effective alternative to genomic testing and aiding personalized treatment.
thelancet.com
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
We developed an AI-based method that can provide an accurate, timely, and economical prediction of gene mutation and mutation spatial distribution. The method showed substantial potential as an assist...
000
Yong Li @precisionmedicine.bsky.social · 08/02/2025
The biopharma industry is changing for the better! Over the past three years, 70% of FDA-approved precision medicines came from outside big pharma. Smaller biotech companies are stepping up, bringing their innovations to market on their own! #PrecisionMedicine @biocentury.bsky.social
biocentury.com
Biotechs make inroads to precision medicine, solving long-standing problems
Recent drug approvals show small and medium-sized players are becoming increasingly successful at navigating the obstacles to get precision therapies acros...
210
Yong Li @precisionmedicine.bsky.social · 07/02/2025
The NIH’s RECOVER Initiative advances #LongCovid research. Despite overlapping symptoms, #MECFS remains underfunded and overlooked. Advocates urge increased research and funding to improve treatments and care. Great opinion piece by W Ian Lipkin & Elizabeth Ansell on @statsnews.bsky.social !
statnews.com
NIH must address the twin crises of long Covid and ME/CFS — together
NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER Initiative.
1153
Yong Li @precisionmedicine.bsky.social · 03/02/2025
A @naturemedicine.bsky.social study presents SCORPIO, an AI tool predicting cancer patients’ response to immune checkpoint inhibitors using routine blood tests. Trained on 9,745 patients, it outperformed PD-L1 staining and tumor mutational burden, highlighting AI’s potential in precision oncology.
nature.com
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data - Nature Medicine
Using multiple datasets from real-world evidence and completed trials, a machine learning model using routine blood and clinical data is shown to be predictive of patient response to immune checkpoint...
070
Yong Li @precisionmedicine.bsky.social · 03/02/2025
A nationwide study of 58 million people in England found that patients with rare diseases had higher COVID-19 mortality rates, particularly those with conditions like bullous pemphigoid. It also highlighted the value of large-scale data in improving rare disease care and public health strategies.
thelancet.com
Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study
Our study highlights that national-scale EHRs provide a unique resource to estimate detailed prevalence, clinical, and demographic data for rare diseases. Using COVID-19-related mortality analysis, we...
020
Yong Li @precisionmedicine.bsky.social · 03/02/2025
A recent review on Pharmaco-Multiomics dives into the genetic and molecular sciences—think genomics, epigenetics, proteomics, metabolomics, and more—to shake up precision psychiatry. The #pharmacogenomics (PGx) family is getting bigger.
mdpi.com
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry
The landscape of psychiatric care is poised for transformation through the integration of pharmaco-multiomics, encompassing genomics, proteomics, metabolomics, transcriptomics, epigenomics, and microb...
030
Yong Li @precisionmedicine.bsky.social · 03/02/2025
A review article on dietary supplements for #MECFS examined 14 studies (N=809). Some interventions (L-carnitine, CoQ10–selenium) showed reductions in #fatigue, despite challenges like small sample sizes & data gaps. Secondary outcomes like cognitive function and inflammation were mixed. #LongCovid
mdpi.com
Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systematic Review
Background/Objectives: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex neuroimmunological disorder with limited treatment options. Despite the widespread use of Dietary Supple...
041
Yong Li @precisionmedicine.bsky.social · 03/02/2025
Pediatric solid tumors were thought non-immunogenic, but new research reveals why and how immune activity varies. A study of 191 children shows age & tumor type shape immunity, with T cell activity linked to mutation rates. Findings aim to advance #PrecisionOncology for children. #immunotherapies
cell.com
Systems-level immunomonitoring in children with solid tumors to enable precision medicine
In a population-based cohort of 191 children with diverse solid tumors, systems-level analyses unravel immune variation with age and tumor type and provide a reference for future precision immunothera...
010
Yong Li @precisionmedicine.bsky.social · 03/02/2025
A new Nature Digital Medicine article explores AI and machine learning in healthcare, focusing on precision oncology. It highlights advancements in diagnostics, treatment, and clinical trials while addressing challenges in data, algorithms, and clinical integration.
nature.com
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology - npj Digital Medicine
npj Digital Medicine - Convergence of evolving artificial intelligence and machine learning techniques in precision oncology
000
Yong Li @precisionmedicine.bsky.social · 02/02/2025
UK researchers released first ever national strategy for cancer vaccine development, focusing on pre-cancer biology & tumor-specific proteins to create preventive vaccines. They highlight mRNA tech’s potential for personalized treatments, aligning with GSK & Oxford’s £50M cancer vaccine initiative.
news-medical.net
UK researchers outline strategy for cancer vaccine advancements
UK oncology researchers have come together to write the first ever national thought leadership strategy report into cancer vaccine advances and the opportunities these present for those affected by ca...
030
Yong Li @precisionmedicine.bsky.social · 01/02/2025
Myriad Genetics’ new study shows NIPT with AMPLIFY™ tech delivers high accuracy at 8 weeks, vs traditional 10+ weeks. AMPLIFY™ boosts fetal cfDNA, enabling earlier & reliable detection of trisomies & sex chromosome aneuploidies. Earlier, reliable screening is here! #NIPT #PrecisionMedicine
biospace.com
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
020
Yong Li @precisionmedicine.bsky.social · 29/01/2025
Signatera tumor-informed ctDNA assay found to influence adjuvant chemotherapy decisions in 16.3% of stage II/III colorectal cancer cases, leading to de-escalation in 59.9%. This underscore ctDNA’s value in guiding treatment. Hoping MRD tests become standard of care soon! #PrecisionOncology
ascopubs.org
Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.
15Background: BESPOKE CRC, a multicenter, prospective, observational study investigated the clinical utility of ctDNA for detecting MRD-based early recurrence in pts with surgically resected CRC. The ...
110
Reposted by Yong Li
Whitney Dafoe @whitneydafoe.bsky.social · 15/01/2025
From Ronald W, Davis, PhD. - HOPE FOR 2025 - I am very optimistic that soon the major mechanisms that initiate the disease will be found. This will allow a concerted effort to reverse the process and find a cure…. New post on my blog: www.whitneydafoe.com/mecfs/?post=... #MECFS #LongCovid
whitneydafoe.com
Ron Davis's message of hope for 2025 and plea for help
I think of you all every day as I work to untangle the complex molecular basis of this horrific disease…I am very optimistic that soon the major mechanisms that initiate the disease will be found. Thi...
37132
Yong Li @precisionmedicine.bsky.social · 26/01/2025
Children with #LongCOVID exhibit distinct blood protein patterns tied to inflammation and vascular changes, resembling findings in adults, according to a new Pediatric Research study. A machine learning model using these proteomic profiles achieved 93% accuracy, 86% specificity, and 97% sensitivity.
nature.com
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls - Pediatric Research
Pediatric Research - Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls
040
Yong Li @precisionmedicine.bsky.social · 24/01/2025
Men face more severe acute COVID-19, but women may have a higher risk of #LongCovid. A new study from JAMA Network Open on 12,276 participants found women had a 1.31x higher risk, with age, pregnancy, and menopausal status influencing outcomes. Hormonal factors may play a key role.
jamanetwork.com
Sex Differences in Long COVID
This cohort study examines whether there are differences in the risk of developing long COVID, or post-COVID condition, by sex.
063
Yong Li @precisionmedicine.bsky.social · 20/01/2025
A informative review article from @digitalmedicine.bsky.social explores how computational and machine learning methods predicts drug interactions, focusing on synergy and antagonism to uncover combos that boost therapy or reduce side effects. #PrecisionMedicine #AI
nature.com
Computational frameworks transform antagonism to synergy in optimizing combination therapies - npj Digital Medicine
npj Digital Medicine - Computational frameworks transform antagonism to synergy in optimizing combination therapies
030